Search by Drug Name or NDC
NDC 52083-0400-01 ZYNCOF 20; 400 mg/5mL; mg/5mL Details
ZYNCOF 20; 400 mg/5mL; mg/5mL
ZYNCOF is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Kramer Novis. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 52083-0400-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 52083-0400-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 52083-0400 |
---|---|
Product ID | 52083-400_0ce3d63e-43c0-43d9-a1ff-cb48da835eee |
Associated GPIs | 43997002521280 |
GCN Sequence Number | 067618 |
GCN Sequence Number Description | guaifenesin/dextromethorphan LIQUID 400-20MG/5 ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 30209 |
HICL Sequence Number | 000223 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
Brand/Generic | Brand |
Proprietary Name | ZYNCOF |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dextromethorphan HBr and Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | SYRUP |
Route | ORAL |
Active Ingredient Strength | 20; 400 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Kramer Novis |
Pharmaceutical Class | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 52083-0400-01 (52083040001)
NDC Package Code | 52083-400-01 |
---|---|
Billing NDC | 52083040001 |
Package | 30 mL in 1 BOTTLE, PLASTIC (52083-400-01) |
Marketing Start Date | 2011-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL cffd6d5f-0cb2-4d38-bdb0-6a21120418cc Details
Uses
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
SPL UNCLASSIFIED SECTION
Keep out of reach of children.
Directions
Other information
Inactive ingredients
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
ZYNCOF
dextromethorphan hbr and guaifenesin syrup |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Kramer Novis (090158395) |